NEW YORK (GenomeWeb News) - Open Biosystems said today it has struck an agreement with UK-based Abcam, under which Open will sell Abcam's research-grade primary antibodies in a combined offering with its own libraries of cDNA, ORF, and shRNA clones.
Open, based in Huntsville, Ala., said researchers will be able to use its web-based gene search tool to query an index of “matched content” that may be used to study genes of interest. The index may be queried by gene symbol or by accession number, the company said.
The combined offering will be used for functional gene analysis, expressing a gene, knocking down a gene and detecting the gene product.
“Traditionally researchers would have to clone their own genes, custom order shRNAs or siRNAs, and search for a separate source of antibodies,” Brian Pollock, CEO of Open, said in a statement. The new agreement “offers the ability to eliminate all of these steps and purchase the products together.”
In addition to its UK headquarters, Abcam has offices in Cambridge, Mass., and in Tokyo.